• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

混合脂质体方法用于紫杉醇和吉西他滨的比率和顺序递药。

Mixed Liposome Approach for Ratiometric and Sequential Delivery of Paclitaxel and Gemcitabine.

机构信息

Jiangsu Jiankang Vocational College, Nanjing, Jiangsu, China.

Department of Industrial and Physical Pharmacy, Purdue University, 575 Stadium Mall Drive, West Lafayette, Indiana, 47907, USA.

出版信息

AAPS PharmSciTech. 2018 Feb;19(2):693-699. doi: 10.1208/s12249-017-0877-z. Epub 2017 Oct 2.

DOI:10.1208/s12249-017-0877-z
PMID:28971370
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5792366/
Abstract

Paclitaxel (PTX) and gemcitabine (GEM) are often used in combination due to the synergistic anticancer effects. PTX and GEM combination showed a synergistic effect to SKOV-3 cells at a molar ratio of 1 to 1 and in PTX ➔ GEM sequence. Liposomes were explored as a carrier of PTX and GEM combination. We optimized the drug loading in liposomes varying the preparation method and co-encapsulated PTX and GEM in a single liposome preparation maintaining the maximum loading efficiency of each drug. However, drug release kinetics from the co-loaded liposomes (LpPG) was suboptimal because of the detrimental effect of PTX on GEM-release control. Instead, a mixture of LpP and LpG, which were separately optimized according to the desired release kinetics, achieved a greater cytotoxic effect than LpPG, due to the attenuation of GEM release relative to PTX. This study illustrates that co-encapsulation in a single carrier is not always desirable for the delivery of drug combinations, when the activity depends on the dosing sequence. These combinations may benefit from the mixed liposome approach, which offers greater flexibility in controlling the ratio and release kinetics of component drugs.

摘要

紫杉醇(PTX)和吉西他滨(GEM)经常联合使用,因为它们具有协同的抗癌作用。在摩尔比为 1:1 时,PTX 和 GEM 联合对 SKOV-3 细胞表现出协同作用,且 PTX➔GEM 顺序具有协同作用。脂质体被探索作为 PTX 和 GEM 联合的载体。我们通过改变制备方法来优化脂质体中的药物载量,并在单个脂质体制剂中共同包封 PTX 和 GEM,以保持每种药物的最大载药效率。然而,由于 PTX 对 GEM 释放控制的不利影响,从共载药脂质体(LpPG)中释放药物的动力学并不理想。相反,根据所需释放动力学分别优化的 LpP 和 LpG 的混合物比 LpPG 具有更大的细胞毒性作用,因为与 PTX 相比,GEM 的释放得到了抑制。本研究表明,当药物的活性取决于给药顺序时,对于药物联合的传递,将其共同包封在单个载体中并不总是理想的。这些组合可能受益于混合脂质体方法,该方法在控制药物成分的比例和释放动力学方面提供了更大的灵活性。

相似文献

1
Mixed Liposome Approach for Ratiometric and Sequential Delivery of Paclitaxel and Gemcitabine.混合脂质体方法用于紫杉醇和吉西他滨的比率和顺序递药。
AAPS PharmSciTech. 2018 Feb;19(2):693-699. doi: 10.1208/s12249-017-0877-z. Epub 2017 Oct 2.
2
Use of a lipid-coated mesoporous silica nanoparticle platform for synergistic gemcitabine and paclitaxel delivery to human pancreatic cancer in mice.使用脂质包被的介孔二氧化硅纳米颗粒平台将吉西他滨和紫杉醇协同递送至小鼠的人胰腺癌中。
ACS Nano. 2015;9(4):3540-57. doi: 10.1021/acsnano.5b00510. Epub 2015 Mar 31.
3
Co-delivery of paclitaxel and gemcitabine by methoxy poly(ethylene glycol)-poly(lactide-coglycolide)-polypeptide nanoparticles for effective breast cancer therapy.甲氧基聚(乙二醇)-聚(丙交酯-乙交酯)-多肽纳米粒共递送紫杉醇和吉西他滨用于有效的乳腺癌治疗
Anticancer Drugs. 2018 Aug;29(7):637-645. doi: 10.1097/CAD.0000000000000631.
4
Antibody fragment-conjugated gemcitabine and paclitaxel-based liposome for effective therapeutic efficacy in pancreatic cancer.抗体片段偶联吉西他滨和紫杉醇的脂质体在胰腺癌中具有有效的治疗效果。
Mater Sci Eng C Mater Biol Appl. 2018 Aug 1;89:328-335. doi: 10.1016/j.msec.2018.04.011. Epub 2018 Apr 11.
5
A new therapeutic combination for osteosarcoma: Gemcitabine and Clofazimine co-loaded liposomal formulation.骨肉瘤的一种新的治疗联合方案:吉西他滨和氯法齐明共载脂质体制剂。
Int J Pharm. 2019 Feb 25;557:97-104. doi: 10.1016/j.ijpharm.2018.12.041. Epub 2018 Dec 23.
6
Synthesis of a gemcitabine-modified phospholipid and its subsequent incorporation into a single microbubble formulation loaded with paclitaxel for the treatment of pancreatic cancer using ultrasound-targeted microbubble destruction.合成一种修饰有吉西他滨的磷脂,并将其随后掺入到一种载紫杉醇的单微泡制剂中,用于使用超声靶向微泡破坏技术治疗胰腺癌。
Eur J Pharm Biopharm. 2021 Aug;165:374-382. doi: 10.1016/j.ejpb.2021.05.018. Epub 2021 May 24.
7
Biodegradable multiblock poly(N-2-hydroxypropyl)methacrylamide gemcitabine and paclitaxel conjugates for ovarian cancer cell combination treatment.可生物降解的多嵌段聚(N-2-羟丙基)甲基丙烯酰胺吉西他滨和紫杉醇缀合物用于卵巢癌细胞联合治疗。
Int J Pharm. 2013 Sep 15;454(1):435-43. doi: 10.1016/j.ijpharm.2013.06.046. Epub 2013 Jul 1.
8
Development of Liposomal Gemcitabine with High Drug Loading Capacity.高载药量脂质体吉西他滨的研制。
Mol Pharm. 2019 Jul 1;16(7):2858-2871. doi: 10.1021/acs.molpharmaceut.8b01284. Epub 2019 Jun 14.
9
Tumor-targeted polymeric nanostructured lipid carriers with precise ratiometric control over dual-drug loading for combination therapy in non-small-cell lung cancer.用于非小细胞肺癌联合治疗的具有精确比例控制双药负载的肿瘤靶向聚合物纳米结构脂质载体。
Int J Nanomedicine. 2017 Mar 2;12:1699-1715. doi: 10.2147/IJN.S121262. eCollection 2017.
10
Thermosensitive and biodegradable hydrogel encapsulating targeted nanoparticles for the sustained co-delivery of gemcitabine and paclitaxel to pancreatic cancer cells.温敏可生物降解水凝胶包载靶向纳米粒用于吉西他滨和紫杉醇持续共递送至胰腺癌细胞。
Int J Pharm. 2021 Jan 25;593:120139. doi: 10.1016/j.ijpharm.2020.120139. Epub 2020 Dec 3.

引用本文的文献

1
Nanocarrier drug delivery systems for gynecological cancer therapeutics.用于妇科癌症治疗的纳米载体药物递送系统。
J Control Release. 2025 Sep 10;385:114028. doi: 10.1016/j.jconrel.2025.114028. Epub 2025 Jul 17.
2
Co-Encapsulation of Multiple Antineoplastic Agents in Liposomes by Exploring Microfluidics.通过微流控技术实现多种抗肿瘤药物在脂质体中的共包封
Int J Mol Sci. 2025 Apr 17;26(8):3820. doi: 10.3390/ijms26083820.
3
Polymer Conjugate as the New Promising Drug Delivery System for Combination Therapy against Cancer.聚合物偶联物作为联合治疗癌症的新型有前途的药物传递系统。

本文引用的文献

1
Co-delivery of paclitaxel and gemcitabine via CD44-targeting nanocarriers as a prodrug with synergistic antitumor activity against human biliary cancer.通过靶向 CD44 的纳米载体共递送紫杉醇和吉西他滨作为前药,对人胆管癌具有协同抗肿瘤活性。
Biomaterials. 2015;53:763-74. doi: 10.1016/j.biomaterials.2015.03.006. Epub 2015 Mar 30.
2
Liposomes as multicompartmental carriers for multidrug delivery in anticancer chemotherapy.脂质体作为多隔室载体在抗癌化疗中的多药传递。
Drug Deliv Transl Res. 2011 Feb;1(1):66-75. doi: 10.1007/s13346-010-0007-x.
3
Use of a lipid-coated mesoporous silica nanoparticle platform for synergistic gemcitabine and paclitaxel delivery to human pancreatic cancer in mice.
Curr Top Med Chem. 2024;24(13):1101-1119. doi: 10.2174/0115680266280603240321064308.
4
Advanced Targeted Drug Delivery of Bioactive Nanomaterials in the Management of Cancer.生物活性纳米材料在癌症治疗中的先进靶向药物递送
Curr Med Chem. 2025;32(14):2711-2730. doi: 10.2174/0109298673283362231220115050.
5
Fine-tuning the sequential drug release of nano-formulated mutual prodrugs dictates the combination effects.微调纳米配方相互前药的顺序药物释放决定了联合效应。
Chem Sci. 2023 Mar 17;14(14):3789-3799. doi: 10.1039/d3sc00550j. eCollection 2023 Apr 5.
6
A review of research progress of antitumor drugs based on tubulin targets.基于微管蛋白靶点的抗肿瘤药物研究进展综述
Transl Cancer Res. 2020 Jun;9(6):4020-4027. doi: 10.21037/tcr-20-682.
7
Recent Advances in Lipid-Based Nanosystems for Gemcitabine and Gemcitabine-Combination Therapy.用于吉西他滨及吉西他滨联合治疗的脂质纳米系统的最新进展
Nanomaterials (Basel). 2021 Feb 27;11(3):597. doi: 10.3390/nano11030597.
8
Enhancing efficacy of gemcitabine in pancreatic patient-derived xenograft mouse models.增强吉西他滨在胰腺癌患者来源的异种移植小鼠模型中的疗效。
Int J Pharm X. 2020 Sep 23;2:100056. doi: 10.1016/j.ijpx.2020.100056. eCollection 2020 Dec.
9
Phospholipid prodrug conjugates of insoluble chemotherapeutic agents for ultrasound targeted drug delivery.不溶性化疗药物的磷脂前药缀合物用于超声靶向药物递送。
Nanotheranostics. 2020 Jan 1;4(1):40-56. doi: 10.7150/ntno.37738. eCollection 2020.
10
Gemcitabine Combination Nano Therapies for Pancreatic Cancer.用于胰腺癌的吉西他滨联合纳米疗法
Pharmaceutics. 2019 Nov 4;11(11):574. doi: 10.3390/pharmaceutics11110574.
使用脂质包被的介孔二氧化硅纳米颗粒平台将吉西他滨和紫杉醇协同递送至小鼠的人胰腺癌中。
ACS Nano. 2015;9(4):3540-57. doi: 10.1021/acsnano.5b00510. Epub 2015 Mar 31.
4
Strategies to maximize liposomal drug loading for a poorly water-soluble anticancer drug.用于提高难溶性抗癌药物脂质体载药量的策略。
Pharm Res. 2015 Apr;32(4):1451-61. doi: 10.1007/s11095-014-1551-8. Epub 2014 Oct 30.
5
Multifunctional nanocarriers for simultaneous encapsulation of hydrophobic and hydrophilic drugs in cancer treatment.用于癌症治疗中同时封装疏水和亲水药物的多功能纳米载体。
Nanomedicine (Lond). 2014 Jul;9(10):1499-515. doi: 10.2217/nnm.14.97.
6
Recent progress in multidrug delivery to cancer cells by liposomes.脂质体介导的癌细胞多药递送的最新进展
Nanomedicine (Lond). 2014;9(8):1117-20. doi: 10.2217/nnm.14.62.
7
Sequential combination therapy of ovarian cancer with degradable N-(2-hydroxypropyl)methacrylamide copolymer paclitaxel and gemcitabine conjugates.聚 N-(2-羟丙基)甲基丙烯酰胺共聚物紫杉醇和吉西他滨缀合物序贯联合治疗卵巢癌。
Proc Natl Acad Sci U S A. 2014 Aug 19;111(33):12181-6. doi: 10.1073/pnas.1406233111. Epub 2014 Aug 4.
8
Development of high-content gemcitabine PEGylated liposomes and their cytotoxicity on drug-resistant pancreatic tumour cells.高含量吉西他滨聚乙二醇化脂质体的研制及其对耐药胰腺肿瘤细胞的细胞毒性
Pharm Res. 2014 Oct;31(10):2583-92. doi: 10.1007/s11095-014-1353-z. Epub 2014 Mar 18.
9
Polydopamine-based simple and versatile surface modification of polymeric nano drug carriers.基于聚多巴胺的聚合物纳米药物载体的简单通用表面修饰
ACS Nano. 2014 Apr 22;8(4):3347-56. doi: 10.1021/nn405809c. Epub 2014 Mar 19.
10
Albumin-bound paclitaxel plus gemcitabine in pancreatic cancer.白蛋白结合型紫杉醇联合吉西他滨治疗胰腺癌
N Engl J Med. 2014 Jan 30;370(5):479-80. doi: 10.1056/NEJMc1314761.